Biotech firm Roivant Sciences raises $200 million in a funding round
Date: 2018-11-19   Author: Ojaswita Kutepatil  Category: #news

Biotech firm Roivant Sciences raises $200 million in a funding round

Roivant Sciences, a Swiss company developing innovative drugs across a wide variety of therapeutic areas, and with backing from Japan’s SoftBank, has recently announced that it has raised USD 200 million in equity investment. Reportedly, the investment round has given the company a whopping valuation of USD 7 billion.

Citing sources familiar with the matter, most of the funding came from new financiers RTW Investments and NovaQuest Capital Management among others. They further claim that the drug maker made it to the headlines last year in August when it booked USD 1.1 billion of equity investment from the SoftBank Vision Fund.

Roivant Sciences, for the record is a part of a family of companies that was started by hedge fund manager and entrepreneur Vivek Ramaswamy, who has also founded a public trading firm Axovant Sciences. The company has several subsidiaries, including Myovant and Enzyvant, and are collectively referred as the Vants.

Since SoftBanks’ financing last year, reports reveal that the number of Vants has taken a major jump from six to fourteen, and the number of employees has surged from nearly 350 to over 750.

According to reports, the company is currently anticipating topline data from six Phase III trials scheduled for next year. The product candidates include vibegron, for overactive bladder & IBS-associated pain; relugolix, for endometriosis, uterine fibroids, and prostate cancer; derazantinib, for intrahepatic cholangiocarcinoma; and lefamulin, for community-acquired bacterial pneumonia; among others.

Several other products are reported to be in preclinical, Phase I, and Phase II development, and Roivant Sciences’ subsidiary Enzyvant has also filed for FDA approval for another RVT-802. The company, in total has over 30 investigational drugs around 14 therapeutics areas.

Roivant Sciences and its Vants have now raised over USD 3 billion altogether. Despite a bumpy couple of years, the four-year old company isn’t stopping financiers from slipping money.



About Author


Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Content writer, where she pens down write-ups pertaining to the market res...

Read More

More from Ojaswita


Post Recommendents

Grab to charge fee for ride cancellation in Malaysia from March 25
Author: Pankaj Singh

Reports confirm that from March 25 this year, Grab Malaysia would begin charging its passengers a fee for canceling rides and also those who are late to their hired cab, after a specific permitted time.


NII sells Nextel Brazil’s operation to America Movil for $905 million
Author: Paroma Bhattacharya

Latin American carrier America Movil has reportedly announced that it would acquire NII-owned Nextel Brazil for $905 million. Once the deal is closed, NII will receive approval to dissolve and wind up, stated sources.<...


Toyota and Nvidia to expand partnership for autonomous car technology
Author: Pankaj Singh

Reports indicate that Toyota Motor Corp. is expanding its relationship with Nvidia, as the automaker and its research units based in Japan and the U.S. look to speed up its autonomous vehicle development program.

...